傳復星旗下豫園股份擬參與海航航空資產重組 出資不逾400億人幣
復星國際(00656.HK)旗下豫園股份(600655.SH)公布,豫園股份下屬企業「豫航產業」,擬聯合關聯方以及戰略投資人,出資不超過400億元人民幣(下同),設立合夥企業,參與投資航空實體企業,並向後者支付保證金5億元。
據《第一財經》報道,公告未點出具體是哪一家航空實體企業,但據知情人士透露,該航空實體企業正是處於破產重整進程中的海航控股(600221.SH)。目前海航控股引進戰略投資者的工作進展順利,已有四家潛在意向方報名在洽談,其中,復星和吉祥就是四家中的兩家。
此次豫園股份公布也意味著,復星將通過豫園股份牽頭成立的合夥企業,參與海航航空板塊的重整。(ta/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.